UNITED THERAPEUTICS Corp

UTHR Nasdaq SEC CIK 1082554
Follow United Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $832.5M +4.1% vs same quarter last year
Net income $258.6M −23.6% vs same quarter last year
EPS, diluted $5.71 −20.3% vs same quarter last year
Operating cash flow $306.5M −45.5% vs same quarter last year
Revenue by quarter
$735.9M
$794.4M
$798.6M
$799.5M
$790.2M
$781.5M
$783.3M
$832.5M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$1B$0$1B$2B$3B$4BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$3.2B$1.3B
FY24$2.9B$1.2B
FY23$2.3B$984.8M
FY22$1.9B$727.3M
FY21$1.7B$475.8M
FY20$1.5B$514.8M
FY19$1.4B−$104.5M
FY18$1.6B$589.2M
FY17$1.7B$417.9M
FY16$1.6B$713.7M
FY15$1.5B$651.6M
FY14$1.3B$340.1M
FY13$1.1B$174.6M
FY12$916.1M$304.4M
FY11$743.2M$217.9M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%0%50%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2587.9%46.9%41.9%
FY2489.2%47.9%41.5%
FY2388.9%50.9%42.3%
FY2292.2%50.6%37.6%
FY2192.7%33%28.2%
FY2092.7%40%34.7%
FY1991.9%−12.9%−7.2%
FY1887.8%49.5%36.2%
FY1793.9%47.2%24.2%
FY1695.5%66.4%44.6%
FY1595.3%47.7%44.5%
FY1489.5%41.8%26.4%
FY1387.4%26.2%15.6%
FY1285.9%46%33.2%
FY1187.8%42.8%29.3%
Free cash flowOperating cash flow minus capital expenditure
−$500M$0$500M$1B$1.5BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$1B
FY24$1.1B
FY23$747.6M
FY22$663.7M
FY21$477.4M
FY20$696.4M
FY19−$290.3M
FY18$594M
FY17$387.9M
FY16$605.6M
FY15$333M
FY14$307.9M
FY13$393.4M
FY12$211.7M
FY11$214.2M
Returned to shareholdersDividends paid and shares bought back
$0$250M$500M$750M$1BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$1B
FY24$1B
FY23$0
FY22$0
FY21-
FY20-
FY19-
FY18-
FY17$250M
FY16$500M
FY15$394.5M
FY14$483.1M
FY13$42.4M
FY12$188M
FY11$212M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • United Therapeutics
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearUnited TherapeuticsHealthcare median
FY2541.9%−30.6%
FY2441.5%−47%
FY2342.3%−58%
FY2237.6%−80.4%
FY2128.2%−71.9%
FY2034.7%−62.2%
FY19−7.2%−46.3%
FY1836.2%−49.6%
FY1724.2%−45.9%
FY1644.6%−36%
FY1544.5%−38.4%
FY1426.4%−35.5%
FY1315.6%−37.1%
FY1233.2%−29.1%
FY1129.3%−27.9%